1

Alirocumab (1245916-14-6): A Deep Dive

wcd118122484
Alirocumab, cataloged as 1245916-14-6, signifies a innovative monoclonal antibody specifically to inhibit proprotein convertase PCSK9 – a crucial modulator of low-density lipoprotein concentrations . https://www.targetmol.com/compound/alirocumab
Report this page

Comments

    HTML is allowed

Who Upvoted this Story